
Sign up to save your podcasts
Or


2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocates for sickle cell patients.
By Biotechnology Innovation Organization4.9
8383 ratings
2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocates for sickle cell patients.

2,059 Listeners

762 Listeners

761 Listeners

601 Listeners

821 Listeners

310 Listeners

113,199 Listeners

508 Listeners

399 Listeners

123 Listeners

340 Listeners

120 Listeners

153 Listeners

284 Listeners

261 Listeners